PTHL Pheton Holdings Ltd Class A Ordinary Shares

Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 31/74 ]

NASDAQ | Common Stock

Price: $3.30

Increased by +3.61%
Dollar volume (20D): 267.23 K
ADR%: 34.34

Shares float: 3.18 M
Shares short: 11.58 K [0.36%]
Shares outstanding: 6.58 M

Market cap: 55.68 M
Beta: N/A
Price/earnings: N/A

20D range: 1.32 5.00
50D range: 1.32 5.00
200D range: 1.32 6.45

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.

The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.

Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.

The company was founded in 1998 and is based in Beijing, China.

Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.

Quarterly earnings
Annual earnings

Reported date	EPSChange YoY	EstimateSurprise

Quarterly financials
Annual financials

Fiscal ending date	RevenueChange YoY	IncomeChange YoY	ProfitChange YoY